The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Von Seebach competitive analysis

Loading summary...

Latest oppositions filed by Von Seebach

Explore patent oppositions filed by Von Seebach against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3453387
Dosage Regimen For A S1P Receptor AgonistNOVARTISMar 3, 2021
EP3409274
Dosage Regimen For A S1P Receptor AgonistNOVARTISAug 18, 2020
EP3246021
Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDAug 6, 2020

Latest PTAB cases involving Von Seebach

Discover the latest PTAB cases involving Von Seebach, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Von Seebach with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
VON SEEBACH3 - - -
BRISTOL MYERS SQUIBB IRELAND - 43 - -
BRISTOL MYERS SQUIBB IRELAND UNLIMITED - 43 - -
NOVARTIS6422 - 21